A Study of Humanized BCMA-targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma
NCT04670055
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Relapse Multiple Myeloma
Refractory Multiple Myeloma
Interventions
DRUG:
BCMA Targeted CAR T-cells
Sponsor
Zhejiang University
Collaborators
[object Object]